Functionalized carbon nanotubes as immunomodulator systems

Mario Pescatori, Davide Bedognetti, Enrica Venturelli, Cécilia Ménard-Moyon, Camilla Bernardini, Elena Muresu, Andrea Piana, Giorgio Maida, Roberto Manetti, Francesco Sgarrella, Alberto Bianco, Lucia Gemma Delogu

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

In view of the broad potential biomedical applications of carbon nanotubes (CNTs) different studies were performed to assess their effect on the immune system. However, the work performed to date was able to give a restricted view looking only at some activation markers and cytokine expression. The immune system is rarely limited to few molecule interactions being instead always a balance of switching several genes on and off. Whole genome expression (microarray) is a technology able to give the full picture on genome expression. Here we describe a microarray genome-wide study on Jurkat cells, a T lymphocyte cell line, and THP1, a monocytic cell line, representative of both types of immune response, the adaptive and innate, respectively. Since any structure or molecule modification may lead to very different immune reactions, we treated the two cell lines with four types of functionalized multi-walled CNTs that differ in terms of functionalization and diameter. After having assessed the internalization and the lack of toxicity of CNTs in both cell types, we used the Affymetrix technology to analyze the expression of about 32,000 transcripts. Three of the tested nanotubes (i.e., ox-MWCNT-1, ox-MWCNT-. NH3+-1, and ox-MWCNT-. NH3+-2) activated immune-related pathways in monocytes but not in T cells. In view of these charateristics they were named as monocyte activating CNTs (MA-CNTs). Molecular pathways upregulated by MA-CNTs included IL6, CD40, dendritic cell maturation, tumor necrosis factor-(TNF)-α/TNFR1-2, NFKB signaling and T helper 1 chemokine pathways (CXCR3 and CCR5 ligand pathways). These pathways are commonly activated during acute inflammatory processes as those associated with immune-mediated tumor rejection and pathogen clearance. One of them (i.e., ox-MWCNT-2) downregulated genes associated with ribosomal proteins in both monocytes and T cells. We validated our findings at gene expression level by performing real-time PCR assessing the most highly modulated genes in monocytes. To confirm the results at protein level, the secretion of IL1β, TNFα, IL6 and IL10 by THP1 and primary monocytes was assessed by ELISA, corroborating gene-expression data. Our results provide new insights into the whole gene expression modulation by different CNTs on immune cells. Considering the well known drug carrier ability of CNTs, our findings demonstrate that MA-CNTs here behave as cell specific immunostimulatory systems, giving very interesting future perspectives for their application also as immunotherapeutic agents and/or vaccine adjuvants.

Original languageEnglish
Pages (from-to)4395-4403
Number of pages9
JournalBiomaterials
Volume34
Issue number18
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Fingerprint

Carbon Nanotubes
Immunologic Factors
Monocytes
Carbon nanotubes
Genes
T-cells
Gene expression
Immune system
Cells
Microarrays
Genome
T-Lymphocytes
Interleukin-6
Gene Expression
Cell Line
Antigen-antibody reactions
Immune System
Receptors, Tumor Necrosis Factor, Type I
Proteins
Drug Carriers

Keywords

  • Carbon nanomaterials
  • Cytokines
  • Gene expression
  • Immune system
  • Microarrays
  • Nanomedicine

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Pescatori, M., Bedognetti, D., Venturelli, E., Ménard-Moyon, C., Bernardini, C., Muresu, E., ... Delogu, L. G. (2013). Functionalized carbon nanotubes as immunomodulator systems. Biomaterials, 34(18), 4395-4403. https://doi.org/10.1016/j.biomaterials.2013.02.052

Functionalized carbon nanotubes as immunomodulator systems. / Pescatori, Mario; Bedognetti, Davide; Venturelli, Enrica; Ménard-Moyon, Cécilia; Bernardini, Camilla; Muresu, Elena; Piana, Andrea; Maida, Giorgio; Manetti, Roberto; Sgarrella, Francesco; Bianco, Alberto; Delogu, Lucia Gemma.

In: Biomaterials, Vol. 34, No. 18, 06.2013, p. 4395-4403.

Research output: Contribution to journalArticle

Pescatori, M, Bedognetti, D, Venturelli, E, Ménard-Moyon, C, Bernardini, C, Muresu, E, Piana, A, Maida, G, Manetti, R, Sgarrella, F, Bianco, A & Delogu, LG 2013, 'Functionalized carbon nanotubes as immunomodulator systems', Biomaterials, vol. 34, no. 18, pp. 4395-4403. https://doi.org/10.1016/j.biomaterials.2013.02.052
Pescatori M, Bedognetti D, Venturelli E, Ménard-Moyon C, Bernardini C, Muresu E et al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials. 2013 Jun;34(18):4395-4403. https://doi.org/10.1016/j.biomaterials.2013.02.052
Pescatori, Mario ; Bedognetti, Davide ; Venturelli, Enrica ; Ménard-Moyon, Cécilia ; Bernardini, Camilla ; Muresu, Elena ; Piana, Andrea ; Maida, Giorgio ; Manetti, Roberto ; Sgarrella, Francesco ; Bianco, Alberto ; Delogu, Lucia Gemma. / Functionalized carbon nanotubes as immunomodulator systems. In: Biomaterials. 2013 ; Vol. 34, No. 18. pp. 4395-4403.
@article{b470bc586aa4454fad7edffa7c17d14d,
title = "Functionalized carbon nanotubes as immunomodulator systems",
abstract = "In view of the broad potential biomedical applications of carbon nanotubes (CNTs) different studies were performed to assess their effect on the immune system. However, the work performed to date was able to give a restricted view looking only at some activation markers and cytokine expression. The immune system is rarely limited to few molecule interactions being instead always a balance of switching several genes on and off. Whole genome expression (microarray) is a technology able to give the full picture on genome expression. Here we describe a microarray genome-wide study on Jurkat cells, a T lymphocyte cell line, and THP1, a monocytic cell line, representative of both types of immune response, the adaptive and innate, respectively. Since any structure or molecule modification may lead to very different immune reactions, we treated the two cell lines with four types of functionalized multi-walled CNTs that differ in terms of functionalization and diameter. After having assessed the internalization and the lack of toxicity of CNTs in both cell types, we used the Affymetrix technology to analyze the expression of about 32,000 transcripts. Three of the tested nanotubes (i.e., ox-MWCNT-1, ox-MWCNT-. NH3+-1, and ox-MWCNT-. NH3+-2) activated immune-related pathways in monocytes but not in T cells. In view of these charateristics they were named as monocyte activating CNTs (MA-CNTs). Molecular pathways upregulated by MA-CNTs included IL6, CD40, dendritic cell maturation, tumor necrosis factor-(TNF)-α/TNFR1-2, NFKB signaling and T helper 1 chemokine pathways (CXCR3 and CCR5 ligand pathways). These pathways are commonly activated during acute inflammatory processes as those associated with immune-mediated tumor rejection and pathogen clearance. One of them (i.e., ox-MWCNT-2) downregulated genes associated with ribosomal proteins in both monocytes and T cells. We validated our findings at gene expression level by performing real-time PCR assessing the most highly modulated genes in monocytes. To confirm the results at protein level, the secretion of IL1β, TNFα, IL6 and IL10 by THP1 and primary monocytes was assessed by ELISA, corroborating gene-expression data. Our results provide new insights into the whole gene expression modulation by different CNTs on immune cells. Considering the well known drug carrier ability of CNTs, our findings demonstrate that MA-CNTs here behave as cell specific immunostimulatory systems, giving very interesting future perspectives for their application also as immunotherapeutic agents and/or vaccine adjuvants.",
keywords = "Carbon nanomaterials, Cytokines, Gene expression, Immune system, Microarrays, Nanomedicine",
author = "Mario Pescatori and Davide Bedognetti and Enrica Venturelli and C{\'e}cilia M{\'e}nard-Moyon and Camilla Bernardini and Elena Muresu and Andrea Piana and Giorgio Maida and Roberto Manetti and Francesco Sgarrella and Alberto Bianco and Delogu, {Lucia Gemma}",
year = "2013",
month = "6",
doi = "10.1016/j.biomaterials.2013.02.052",
language = "English",
volume = "34",
pages = "4395--4403",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "18",

}

TY - JOUR

T1 - Functionalized carbon nanotubes as immunomodulator systems

AU - Pescatori, Mario

AU - Bedognetti, Davide

AU - Venturelli, Enrica

AU - Ménard-Moyon, Cécilia

AU - Bernardini, Camilla

AU - Muresu, Elena

AU - Piana, Andrea

AU - Maida, Giorgio

AU - Manetti, Roberto

AU - Sgarrella, Francesco

AU - Bianco, Alberto

AU - Delogu, Lucia Gemma

PY - 2013/6

Y1 - 2013/6

N2 - In view of the broad potential biomedical applications of carbon nanotubes (CNTs) different studies were performed to assess their effect on the immune system. However, the work performed to date was able to give a restricted view looking only at some activation markers and cytokine expression. The immune system is rarely limited to few molecule interactions being instead always a balance of switching several genes on and off. Whole genome expression (microarray) is a technology able to give the full picture on genome expression. Here we describe a microarray genome-wide study on Jurkat cells, a T lymphocyte cell line, and THP1, a monocytic cell line, representative of both types of immune response, the adaptive and innate, respectively. Since any structure or molecule modification may lead to very different immune reactions, we treated the two cell lines with four types of functionalized multi-walled CNTs that differ in terms of functionalization and diameter. After having assessed the internalization and the lack of toxicity of CNTs in both cell types, we used the Affymetrix technology to analyze the expression of about 32,000 transcripts. Three of the tested nanotubes (i.e., ox-MWCNT-1, ox-MWCNT-. NH3+-1, and ox-MWCNT-. NH3+-2) activated immune-related pathways in monocytes but not in T cells. In view of these charateristics they were named as monocyte activating CNTs (MA-CNTs). Molecular pathways upregulated by MA-CNTs included IL6, CD40, dendritic cell maturation, tumor necrosis factor-(TNF)-α/TNFR1-2, NFKB signaling and T helper 1 chemokine pathways (CXCR3 and CCR5 ligand pathways). These pathways are commonly activated during acute inflammatory processes as those associated with immune-mediated tumor rejection and pathogen clearance. One of them (i.e., ox-MWCNT-2) downregulated genes associated with ribosomal proteins in both monocytes and T cells. We validated our findings at gene expression level by performing real-time PCR assessing the most highly modulated genes in monocytes. To confirm the results at protein level, the secretion of IL1β, TNFα, IL6 and IL10 by THP1 and primary monocytes was assessed by ELISA, corroborating gene-expression data. Our results provide new insights into the whole gene expression modulation by different CNTs on immune cells. Considering the well known drug carrier ability of CNTs, our findings demonstrate that MA-CNTs here behave as cell specific immunostimulatory systems, giving very interesting future perspectives for their application also as immunotherapeutic agents and/or vaccine adjuvants.

AB - In view of the broad potential biomedical applications of carbon nanotubes (CNTs) different studies were performed to assess their effect on the immune system. However, the work performed to date was able to give a restricted view looking only at some activation markers and cytokine expression. The immune system is rarely limited to few molecule interactions being instead always a balance of switching several genes on and off. Whole genome expression (microarray) is a technology able to give the full picture on genome expression. Here we describe a microarray genome-wide study on Jurkat cells, a T lymphocyte cell line, and THP1, a monocytic cell line, representative of both types of immune response, the adaptive and innate, respectively. Since any structure or molecule modification may lead to very different immune reactions, we treated the two cell lines with four types of functionalized multi-walled CNTs that differ in terms of functionalization and diameter. After having assessed the internalization and the lack of toxicity of CNTs in both cell types, we used the Affymetrix technology to analyze the expression of about 32,000 transcripts. Three of the tested nanotubes (i.e., ox-MWCNT-1, ox-MWCNT-. NH3+-1, and ox-MWCNT-. NH3+-2) activated immune-related pathways in monocytes but not in T cells. In view of these charateristics they were named as monocyte activating CNTs (MA-CNTs). Molecular pathways upregulated by MA-CNTs included IL6, CD40, dendritic cell maturation, tumor necrosis factor-(TNF)-α/TNFR1-2, NFKB signaling and T helper 1 chemokine pathways (CXCR3 and CCR5 ligand pathways). These pathways are commonly activated during acute inflammatory processes as those associated with immune-mediated tumor rejection and pathogen clearance. One of them (i.e., ox-MWCNT-2) downregulated genes associated with ribosomal proteins in both monocytes and T cells. We validated our findings at gene expression level by performing real-time PCR assessing the most highly modulated genes in monocytes. To confirm the results at protein level, the secretion of IL1β, TNFα, IL6 and IL10 by THP1 and primary monocytes was assessed by ELISA, corroborating gene-expression data. Our results provide new insights into the whole gene expression modulation by different CNTs on immune cells. Considering the well known drug carrier ability of CNTs, our findings demonstrate that MA-CNTs here behave as cell specific immunostimulatory systems, giving very interesting future perspectives for their application also as immunotherapeutic agents and/or vaccine adjuvants.

KW - Carbon nanomaterials

KW - Cytokines

KW - Gene expression

KW - Immune system

KW - Microarrays

KW - Nanomedicine

UR - http://www.scopus.com/inward/record.url?scp=84875581095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875581095&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.02.052

DO - 10.1016/j.biomaterials.2013.02.052

M3 - Article

VL - 34

SP - 4395

EP - 4403

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 18

ER -